1997
DOI: 10.1378/chest.112.6.1579
|View full text |Cite
|
Sign up to set email alerts
|

Urokinase in the Management of Complicated Parapneumonic Effusions in Children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
56
1
2

Year Published

2000
2000
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(61 citation statements)
references
References 18 publications
2
56
1
2
Order By: Relevance
“…Our review of the literature reveals only a few case reports in which urokinase fibrinolytic therapy was used in the management of complicated pleural effusions in children, 12 and as far as we can tell, ours is the first case in which t-PA (alteplase) was used in the management of a complicated parapneumonic effusion in a pediatric patient. Given the ease of application, apparent safety, and the lack of appreciable side effects, intrapleural t-PA offers a promising treatment alternative in the management of this difficult problem.…”
Section: Discussionmentioning
confidence: 84%
“…Our review of the literature reveals only a few case reports in which urokinase fibrinolytic therapy was used in the management of complicated pleural effusions in children, 12 and as far as we can tell, ours is the first case in which t-PA (alteplase) was used in the management of a complicated parapneumonic effusion in a pediatric patient. Given the ease of application, apparent safety, and the lack of appreciable side effects, intrapleural t-PA offers a promising treatment alternative in the management of this difficult problem.…”
Section: Discussionmentioning
confidence: 84%
“…A grande discussão sobre o uso de fibrinolíticos como tratamento adjuvante em crianças com empiema, é que este tipo de abordagem requer prolongado tempo de internação e tem significativos índices de ineficácia 39 . Associado a isso, não há estudo prospectivo randomizado comparando o uso de fibrinolíticos com outros métodos de tratamento do derrame parapneumônico complicado na criança.…”
Section: Enzimas Intrapleuraisunclassified
“…fibrinolytic therapy; fibrinolysis; plasminogen activator inhibitor 1; pleural injury; urokinase; tissue plasminogen activator INTRAPLEURAL FIBRINOLYTIC THERAPY (IPFT) activates the endogenous fibrinolytic system, resolving intrapleural adhesions and complex fibrinous deposits that sequester pockets of inflammation loculations, thus improving drainage and clinical outcome, in part by decreasing surgical interventions (10). There are multiple reports of successful (88 -100% efficacy) IPFT in adult (1,7,8,16,17,29,42,47,48,66,67,72) and in pediatric (2,3,6,11,20,40,41,58,59,61,63,67) patients with empyema although outcomes in adult patients are inconsistent in these trials. Thus IPFT represents a less invasive and costly alternative to video-assisted thoracic surgery or other surgical interventions, which demonstrate comparable efficacy (16,44,45,58,60,71) in pediatric practice.…”
mentioning
confidence: 99%